Nanobiotix

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Nanobiotix and buy or sell other stocks, ETFs, and their options commission-free!

About NBTX

Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. Its technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells. 

CEO
Laurent Lévy
CEOLaurent Lévy
Employees
97
Employees97
Headquarters
Paris, Ile-de-France
HeadquartersParis, Ile-de-France
Founded
2003
Founded2003
Employees
97
Employees97

NBTX Key Statistics

Market cap
1.92B
Market cap1.92B
Price-Earnings ratio
-66.84
Price-Earnings ratio-66.84
Dividend yield
Dividend yield
Average volume
124.82K
Average volume124.82K
High today
$40.00
High today$40.00
Low today
$37.98
Low today$37.98
Open price
$40.00
Open price$40.00
Volume
107.37K
Volume107.37K
52 Week high
$57.14
52 Week high$57.14
52 Week low
$6.97
52 Week low$6.97

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.